News
US FDA accepts resubmitted NDA of Aldeyra Therapeutics for review of topical ocular reproxalap to treat dry eye disease: Lexington, Massachusetts Saturday, July 19, 2025, 13:00 Hr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback